Patents by Inventor Ji-yeon Kim

Ji-yeon Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8626207
    Abstract: A method of checking for modification of a message transmitted by a transmitting mobile terminal comprises transmitting an original message to a receiving mobile terminal, receiving a report message comprising information about any modification of the original message, and displaying information about the modification of the original message.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: January 7, 2014
    Assignee: LG Electronics Inc.
    Inventor: Ji Yeon Kim
  • Patent number: 8617546
    Abstract: Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: December 31, 2013
    Assignee: Seoul National University Industry Foundation
    Inventors: Chang Yuil Kang, Woo Sung Chang, Ji Yeon Kim, Dong-Hyeon Kim
  • Publication number: 20130258138
    Abstract: Provided are an apparatus and method for generating an image with a defocused background. According to various aspects, a preview image is used as the basis for extracting a background distribution and a defocused background is generated based on the extracted background distribution. Accordingly, it is not necessary to photograph two or more images to generate a defocused background effect.
    Type: Application
    Filed: March 28, 2013
    Publication date: October 3, 2013
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Gengyu MA, Young Su MOON, Wentao MAO, Jeong Uk CHO, Ji Yeon KIM
  • Patent number: 8470551
    Abstract: The present invention relates to a fusion protein in which a myostatin mature protein is fused to a multimer of myostatin-derived antigenic peptide Myo-2, a surface expression vector containing a polynucleotide encoding the fusion protein, a recombinant microorganism transformed with the vector, and a feedstuff additive or a pharmaceutical composition containing the microorganism as an effective ingredient. The feedstuff additive or pharmaceutical composition according to the present invention can be used for muscle development and regulation of muscle growth in livestock and poultry, as well as for preventing and treating muscle-wasting diseases and degenerative diseases such as muscular dystrophy, muscular atrophy and the like. In addition, the transformed strain shows the same effect even if the strain itself after culture thereof is directly used, and thus it is very economical.
    Type: Grant
    Filed: November 30, 2007
    Date of Patent: June 25, 2013
    Assignees: Bioleaders Corporation, Korea Research Institute of Science and Technology, The Industry and Academic Cooperation in Chungnam National University
    Inventors: Moon-Hee Sung, Chul Joong Kim, Haryoung Poo, Ji Yeon Kim, Young Suk Kim, Long Chun Xu
  • Publication number: 20120237522
    Abstract: Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: February 17, 2012
    Publication date: September 20, 2012
    Applicant: Seoul National University Industry Foundation
    Inventors: Chang Yuil KANG, Woo Sung CHANG, Ji Yeon KIM, Dong-Hyeon KIM
  • Publication number: 20120230965
    Abstract: The present invention relates to a novel microorganism producing L-type poly-gamma-glutamic acid and an L-type poly-gamma-glutamic acid produced thereby and, more particularly, to Bacillus megaterium Toha (KCTC11752BP) isolated from salt-fermented Toha shrimps (Korean traditional fermented food) and an L-type poly-gamma-glutamic acid produced thereby. The novel microorganism Bacillus megaterium Toha (KCTC11752BP) has the ability to produce L-type poly-gamma-glutamic acid which can be used in high-value-added microbial agents, probiotic agents, immune-activating agents, animal drugs, cosmetics, moisture absorbers, thickeners, biodegradable plastics, etc.
    Type: Application
    Filed: December 7, 2011
    Publication date: September 13, 2012
    Applicants: BIOLEADERS CORPORATION, THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, KOOKMIN UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Moon-Hee SUNG, Chul Joong KIM, Haryoung POO, Mi-Sun KWAK, Sung-Bin PARK, Dong-Hwan CHOI, Ji Yeon KIM
  • Patent number: 8236940
    Abstract: Disclosed herein are an aldolase gene promoter and the use thereof, more particularly, disclosed are a promoter of aldolase gene derived from Lactobacillus casei, having a base sequence of SEQ ID NO: 1, an expression vector containing said promoter, and a recombinant microorganism transformed with said expression vector. The recombinant microorganism transformed with the expression vector containing the disclosed promoter can effectively express a target protein on the surface thereof, and thus will be useful as vaccine vehicles and the like.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: August 7, 2012
    Assignees: Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology
    Inventors: Moon Hee Sung, Chul Joong Kim, Seung-Pyo Hong, Haryoung Poo, Il Han Lee, Ji Yeon Kim, Kwang Kim
  • Patent number: 8218489
    Abstract: The present invention relates to a scheduling apparatus of a base station supporting Automatic Repeat reQuest (ARQ) method. In particular, the present invention discloses scheduling a data unit transmitted to a mobile station from a base station providing ARQ method for correcting an error in wireless data communication and generating a high rate frame. According to the present invention, there is provided a transmission controlling apparatus comprising a receiver to receive mobile station status information from a mobile station connected with a base station, a schedule managing unit to determine transmission priority of a plurality of data units to be transmitted to the mobile station based on the received mobile station status information, and a transmitter to transmit the data units to the mobile station based on the determined transmission priority.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: July 10, 2012
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Yun Hee Cho, Hyung Jin Kim, Ji Yeon Kim, Gweon Do Jo, Jin Up Kim
  • Patent number: 8121152
    Abstract: A method for encoding a broadcast channel protocol data unit (BCH PDU) based on a broadcast control channel (BCCH) scheduling error in a universal mobile telecommunications system (UMTS) having a Node B and a radio network controller includes setting up a call between the radio network controller and the Node B to receive system information and scheduling information for a system information update from the radio network controller; initializing broadcast channel protocol data units and control information for every system frame number (SFN) at the Node B; and detecting the broadcast control channel scheduling error on the scheduling information for the system information update based on segment types of the system information when combining the system information for every system frame number. In case the broadcast control channel scheduling error is not detected, the broadcast channel protocol data units are encoded to be incorporated therein the system information.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: February 21, 2012
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Yunhee Cho, Ji Yeon Kim, Gweon Do Jo, Jin Up Kim
  • Publication number: 20110223660
    Abstract: Disclosed is a composition for inducing the proliferation of retinal cells or the differentiation of retinal progenitor cells into retinal cells. The composition, similar to in vivo conditions for development during embryogenesis, induces stem cells to differentiate into a multitude of photoreceptor cells at high yield within a short period of time, without an additional gene transfer. In addition, the differentiated photoreceptor cells are useful in cellular therapy because they, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.
    Type: Application
    Filed: October 6, 2010
    Publication date: September 15, 2011
    Applicant: SNU R&DB FOUNDATION
    Inventors: Sung Sup Park, Ji Yeon Kim
  • Publication number: 20110223140
    Abstract: Disclosed is a method for inducing stem cells to differentiate into retinal cells at high yield within a short period of time, without gene implantation and co-culture with retinal tissues, by implementing a differentiation process similar to the in vivo embryonic development in chemically defined conditions. Also, retinal cells including the photoreceptor cells and their progenitor cells, and various types of other retinal cells, generated according to the method, are disclosed. A composition comprising the retinal cells and a method are provided for treating retinal degeneration-related diseases. The differentiated photoreceptor cells, when transplanted into degenerated or injured retinas, can be engrafted and fused within the retinas to prevent or cure retinal degeneration.
    Type: Application
    Filed: October 6, 2010
    Publication date: September 15, 2011
    Applicant: SNU R&DB FOUNDATION
    Inventors: Sung Sup Park, Ji Yeon Kim
  • Patent number: 7901716
    Abstract: Provided is a composition that contains, as an active ingredient, an extract or polysaccharides separated from the leaves and/or stems of plants belonging to Panax genus, for an anticancer drug or its adjuvant, having an effect on the activity of hematopoiesis enhancement, cancer metastasis inhibition, bone marrow defense, etc. . . . , and a process for preparation of the extract from the leaves and/or stems of plants belonging to Panax genus.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: March 8, 2011
    Assignee: MD Bioalpha Co., Ltd.
    Inventors: Tae Hwan Kwak, Myoung Sook Shin, Ji Yeon Kim, Jong-Kook Park
  • Publication number: 20110010756
    Abstract: The present invention relates to a virtual application program system, a storage device, a method of executing a virtual application program, and a method of protecting a virtual environment. The virtual application program system includes an execution control module for executing a virtual application program, and a virtual environment protection module loaded by the execution control module and configured to block non-permitted application programs from accessing a virtual environment accessed by the virtual application program. Accordingly, the virtual environment can be protected from a host application program, etc., and independency and security of a task using a virtual application program can be guaranteed.
    Type: Application
    Filed: December 31, 2008
    Publication date: January 13, 2011
    Applicant: MARKANY Inc.
    Inventors: Jong Uk Choi, Dongha Shin, Sung Wook Jung, Ji Yeon Kim, Muhammad Ali Malik, Samg Yup Shim, Hong Won Lee
  • Publication number: 20100273467
    Abstract: A method of providing a call transfer service and a mobile terminal using the same are provided. When a call connection request signal transmitted to a mobile communication server through a PSTN is received, any one of previously stored phone numbers is selected and a service of transferring a call to the selected phone number according to the received call connection request signal is requested. Therefore, when call connection is requested, it is selected whether a call is to be transferred, when a call is transferred, a phone number to transfer a call can be dynamically selected according to a user situation, and thus user convenience according to call transfer can be improved.
    Type: Application
    Filed: July 29, 2008
    Publication date: October 28, 2010
    Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Hyung Jin Kim, Yun Hee Cho, Ji Yeon Kim, Seong Chul Cho, Gweon Do Jo, Jin Up Kim
  • Publication number: 20100226891
    Abstract: The present invention relates to a fusion protein in which a myostatin mature protein is fused to a multimer of myostatin-derived antigenic peptide Myo-2, a surface expression vector containing a polynucleotide encoding the fusion protein, a recombinant microorganism transformed with the vector, and a feedstuff additive or a pharmaceutical composition containing the microorganism as an effective ingredient. The feedstuff additive or pharmaceutical composition according to the present invention can be used for muscle development and regulation of muscle growth in livestock and poultry, as well as for preventing and treating muscle-wasting diseases and degenerative diseases such as muscular dystrophy, muscular atrophy and the like. In addition, the transformed strain shows the same effect even if the strain itself after culture thereof is directly used, and thus it is very economical.
    Type: Application
    Filed: November 30, 2007
    Publication date: September 9, 2010
    Applicant: BIOLEADERS CORPORATION
    Inventors: Moon-Hee Sung, Chul Joong Kim, Haryoung Poo, Ji Yeon Kim, Young Suk Kim, Long Chun Xu
  • Publication number: 20100196956
    Abstract: Disclosed herein are an aldolase gene promoter and the use thereof, more particularly, disclosed are a promoter of aldolase gene derived from Lactobacillus casei, having a base sequence of SEQ ID NO: 1, an expression vector containing said promoter, and a recombinant microorganism transformed with said expression vector. The recombinant microorganism transformed with the expression vector containing the disclosed promoter can effectively express a target protein on the surface thereof, and thus will be useful as vaccine vehicles and the like.
    Type: Application
    Filed: March 21, 2008
    Publication date: August 5, 2010
    Applicants: Bioleaders Corporation, Korea Research Institute of Bioscience and Biotechnology
    Inventors: Moon Hee Sung, Chul Joong Kim, Seung-Pyo Hong, Haryoung Poo, Il Han Lee, Ji Yeon Kim, Kwang Kim
  • Publication number: 20100086550
    Abstract: Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: March 25, 2009
    Publication date: April 8, 2010
    Applicant: Seoul National University Industry Foundation
    Inventors: Chang Yuil Kang, Woo Sung Chang, Ji Yeon Kim
  • Publication number: 20090147747
    Abstract: The present invention relates to a scheduling apparatus of a base station supporting Automatic Repeat reQuest (ARQ) method. In particular, the present invention discloses scheduling a data unit transmitted to a mobile station from a base station providing ARQ method for correcting an error in wireless data communication and generating a high rate frame. According to the present invention, there is provided a transmission controlling apparatus comprising a receiver to receive mobile station status information from a mobile station connected with a base station, a schedule managing unit to determine transmission priority of a plurality of data units to be transmitted to the mobile station based on the received mobile station status information, and a transmitter to transmit the data units to the mobile station based on the determined transmission priority.
    Type: Application
    Filed: December 5, 2008
    Publication date: June 11, 2009
    Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Yun Hee CHO, Hyung Jin KIM, Ji Yeon KIM, Gweon Do JO, Jin Up KIM
  • Patent number: D635381
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: April 5, 2011
    Assignee: Moen Incorporated
    Inventor: Josephina Ji Yeon Kim
  • Patent number: D635382
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: April 5, 2011
    Assignee: Moen Incorporated
    Inventor: Josephina Ji Yeon Kim